cp 424391 has been researched along with macimorelin in 1 studies
Studies (cp 424391) | Trials (cp 424391) | Recent Studies (post-2010) (cp 424391) | Studies (macimorelin) | Trials (macimorelin) | Recent Studies (post-2010) (macimorelin) |
---|---|---|---|---|---|
34 | 7 | 20 | 23 | 5 | 17 |
Protein | Taxonomy | cp 424391 (IC50) | macimorelin (IC50) |
---|---|---|---|
Growth hormone secretagogue receptor type 1 | Homo sapiens (human) | 0.073 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bidlingmaier, M; Delahaut, P; Fichant, E; Görgens, C; Lange, T; Schilbach, K; Thevis, M; Thomas, A | 1 |
1 other study(ies) available for cp 424391 and macimorelin
Article | Year |
---|---|
Comprehensive insights into the formation of metabolites of the ghrelin mimetics capromorelin, macimorelin and tabimorelin as potential markers for doping control purposes.
Topics: Animals; Biomarkers; Chromatography, Liquid; Dipeptides; Doping in Sports; Female; Ghrelin; Humans; Indoles; Limit of Detection; Male; Piperidines; Pyrazoles; Rats; Reproducibility of Results; Solid Phase Extraction; Tandem Mass Spectrometry; Tryptophan | 2021 |